Inactive Instrument

Highlights Apotheca Biosciences, Inc.

Equities

Apotheca Biosciences, Inc. cancelled the acquisition of 51% of Hemp Bloom LLC.	19/06/20	CI
Apotheca Biosciences, Inc. signed a definitive agreement to acquire 51% of Hemp Bloom LLC.	20/06/19	CI
Apotheca Biosciences, Inc. Reports Earnings Results for the First Quarter Ended April 30, 2019	19/06/19	CI
Apotheca Biosciences Introduces XKAPE by ProMED, Newest Product Line Designed for Independent Grocers & Convenience Stores	18/06/19	CI
Apotheca Biosciences Announces the Incorporation of Its Newly Created Subsidiary ProMED Biosciences, Inc	01/04/19	CI
Apotheca Biosciences Introduces ProMED	15/01/19	CI
Apotheca Biosciences Signs an LOI For Purchase of Nano Creaciones S.A. P.I. de C.V	06/11/18	CI
Apotheca Biosciences and CB Scientific Joint Venture to Market Hemp CBD Infused Energy & Chill Drinks Under Brands DAVA & Magic Dragon High	08/10/18	CI
Apotheca Biosciences Inc. Overviews GameDayRx, CBD & Cannabis Tailor-Made for Athletes	27/09/18	CI
Apotheca Biosciences, Inc. completed the acquisition of Cannabis Leaf, Inc. in a reverse merger transaction.	24/06/18	CI
Apotheca Biosciences Inc. Announces RAPID Launching	05/06/18	CI
Cannabis Leaf Secures the IP Rights for Pain Patch, Apotheca Biosciences’ Pain Alleviation Technology	08/05/18	CI
Apotheca Biosciences, Inc. entered into an agreement to acquire Cannabis Leaf, Inc. in a reverse merger transaction.	06/03/18	CI
FutureLand, Corp. acquired 20% stake in Apotheca Biosciences, Inc. from CB Scientific, Inc..	17/09/17	CI

No results for this search